We have collected information about Andrew Finn Biodelivery Sciences International for you. Follow the links to find out details on Andrew Finn Biodelivery Sciences International.
BioDelivery Sciences (BDSI) is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI is utilizing its novel and proprietary BioErodible MucoAdhesive ... BioDelivery Sciences International, Inc. Scroll to Top ...
https://www.researchgate.net/scientific-contributions/2074896668_Andrew_Finn
Andrew Finn's 9 research works with 83 citations and 461 reads, including: Efficacy and Tolerability of Buccal Buprenorphine in Opioid-Experienced Patients With Moderate to Severe Chronic Low Back ...
https://www.bloomberg.com/profile/person/6783053
Andrew L Finn is Former Exec VP:Product Development at Biodelivery Sciences Intl Inc. See Andrew L Finn's compensation, career history, education, & memberships.Works For: Biodelivery Sciences Intl Inc
https://www.researchgate.net/scientific-contributions/15438989_Andrew_L_Finn
Andrew L Finn's research while affiliated with BioDelivery Sciences International, Inc. and other places. Overview. Publications (14)
http://ir.bdsi.com/news-events/news-releases
11 rows · Mar 12, 2020 · The Investor Relations website contains information about BioDelivery …
http://ir.bdsi.com/news-releases/news-release-details/biodelivery-sciences-announces-organizational-changes
Dec 16, 2015 · RALEIGH, N.C., Dec. 16, 2015 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced a number of changes to it senior management staff. BDSI has promoted Dr. Niraj Vasisht to Senior Vice President and Chief Technology Officer, and Albert J. Medwar has been promoted to Senior Vice President, Corporate and Business Development.
https://www.prnewswire.com/news-releases/biodelivery-sciences-announces-organizational-changes-300194126.html
Dec 16, 2015 · About BioDelivery Sciences International. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) is a specialty pharmaceutical company with …Twitter: @BioDeliverySI
https://www.linkedin.com/in/andrew-finn-a8824326
View Andrew Finn’s profile on LinkedIn, the world's largest professional community. ... BioDelivery Sciences International. ... See others named Andrew Finn Learn the skills Andrew has.Title: Pharmaceutical Product …
https://seekingalpha.com/article/3005616-biodelivery-sciences-international-bdsi-ceo-mark-sirgo-on-q4-2014-results-earnings-call-transcript
BioDelivery Sciences International (BDSI) CEO Mark Sirgo on Q4 2014 Results - Earnings Call Transcript. Mar. 16, 2015 11:43 PM ET ... Andrew Finn. Hi, Charles. Yes, we’re actually only ...Author: SA Transcripts
https://www.drugs.com/availability/generic-belbuca.html
Transmucosal delivery devices with enhanced uptake Patent 9,655,843 Issued: May 23, 2017 Assignee(s): BioDelivery Sciences International, Inc. The present invention provides methods for enhancing transmucosal uptake of a medicament, e.g., fentanyl or buprenorphine, to …4.4/10
Searching for Andrew Finn Biodelivery Sciences International?
You can just click the links above. The data is collected for you.
